3,4-methylenedioxyamphetamine has been researched along with heroin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andries, S; Bossaert, L; Demey, HE; Heytens, L; Jorens, PG; Ricaurte, GA; Schepens, PJ | 1 |
Fierro, MF; Moore, KA; Mozayani, A; Poklis, A | 1 |
Barrio Anta, G; de la Fuente de Hoz, L; Rodríguez Arenas, MA; Sánchez Payá, J; Vicente Orta, J | 1 |
Bogusz, MJ | 1 |
Mirken, B | 1 |
Cobain, K; Corkery, J; Ghodse, AH; Jambert-Gray, R; Martinotti, G; Oyefeso, A; Schifano, F | 1 |
Ju, H; Lei, J; Qiang, W; Sheng, J; Song, C; Zhai, C; Zhang, D | 1 |
Burgueño, MJ; Castro, MÁ; Mateos-Campos, R; Sánchez, S | 1 |
1 review(s) available for 3,4-methylenedioxyamphetamine and heroin
Article | Year |
---|---|
Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Cocaine; Fatal Outcome; Gas Chromatography-Mass Spectrometry; Heroin; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Stereoisomerism; Tissue Distribution | 1996 |
7 other study(ies) available for 3,4-methylenedioxyamphetamine and heroin
Article | Year |
---|---|
Acute poisoning with amphetamines (MDEA) and heroin: antagonistic effects between the two drugs.
Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Adult; Confusion; Critical Care; Designer Drugs; Drug Antagonism; Drug Monitoring; Heroin; Humans; Male; Narcotics; Suicide, Attempted; Time Factors | 1996 |
[Epidemiology of designer drug use in Spain].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Cocaine; Designer Drugs; Female; Heroin; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Spain; Substance-Related Disorders | 1997 |
On acute poisoning with amphetamines.
Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Designer Drugs; Heroin; Humans; Narcotic Antagonists; Narcotics; Substance-Related Disorders | 1998 |
Danger: possibly fatal interactions between ritonavir and "ecstasy," some other psychoactive drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Cocaine; Drug Interactions; Fatal Outcome; Hallucinogens; Heroin; HIV Protease Inhibitors; Humans; Illicit Drugs; Male; Methadone; Ritonavir | 1997 |
Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002.
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamine-Related Disorders; Benzodiazepines; Cannabinoids; Cocaine; Drug Interactions; England; Ethanol; Female; Hallucinogens; Heroin; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Wales | 2003 |
Disposable microfluidic device with ultraviolet detection for highly resolved screening of illicit drugs.
Topics: 3,4-Methylenedioxyamphetamine; Disposable Equipment; Dronabinol; Ephedrine; Equipment Design; Heroin; Humans; Illicit Drugs; Ketamine; Limit of Detection; Microfluidic Analytical Techniques; Morphine; Morphine Derivatives; Reproducibility of Results; Substance Abuse Detection; Ultraviolet Rays | 2009 |
[High-risk drug use: epidemiological pattern through hair testing in the forensic context].
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Adult; Amphetamine; Cannabinoids; Cocaine; Cross-Sectional Studies; Female; Forensic Sciences; Gas Chromatography-Mass Spectrometry; Hair; Heroin; Humans; Illicit Drugs; Ketamine; Male; Methadone; Methamphetamine; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Spain; Substance Abuse Detection; Substance-Related Disorders; Young Adult | 2019 |